The European AI in antibody identification market is witnessing a considerable surge, driven primarily by rising investments in biotechnology and a stronger focus on personalized medicine. Analysts anticipate important advancements in therapeutic antibody development utilizing artificial intelligence, particularly within fields like oncology and im